Your browser doesn't support javascript.
loading
Androgen deprivation therapy for prostate cancer and the risk of autoimmune diseases.
Liu, Jui-Ming; Yu, Cheng-Ping; Chuang, Heng-Chang; Wu, Chun-Te; Hsu, Ren-Jun.
Afiliação
  • Liu JM; Division of Urology, Department of Surgery, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan.
  • Yu CP; Faculty of Medicine, National Yang-Ming University, Taipei, Taiwan.
  • Chuang HC; Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan.
  • Wu CT; Department of Pathology and Graduate Institute of Pathology and Parasitology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
  • Hsu RJ; Division of Urology, Department of Surgery, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan.
Prostate Cancer Prostatic Dis ; 22(3): 475-482, 2019 09.
Article em En | MEDLINE | ID: mdl-30692587
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Doenças Autoimunes / Antagonistas de Androgênios / Androgênios Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Doenças Autoimunes / Antagonistas de Androgênios / Androgênios Idioma: En Ano de publicação: 2019 Tipo de documento: Article